Exploring the Metabolic Implications of Dextrin and Maltodextrin on Type 2 Diabetes Mellitus and Insulin Resistance: Experimental Glycemic Risk Analysis (Part 2)

Authors

  • Hassan Darwish Physical Sciences Program, School of Arts, Sciences, and Education, Ivy Tech Community College, South Bend, Indiana, USA Author
  • Evan R Brewer Physical Sciences Program, School of Arts, Sciences, and Education, Ivy Tech Community College, South Bend, Indiana, USA Author
  • Lucas Nathaniel Mechling Physical Sciences Program, School of Arts, Sciences, and Education, Ivy Tech Community College, South Bend, Indiana, USA Author
  • Hagar M. Mohamed Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt Author
  • Manohar Noone Noon’s Clinic, Muscat, Oman Author
  • Abir Ba Hajjaj Lab Department, Microbiology Section, Sultan Qaboos Hospital (SQH), Oman Author
  • Una Gibbons Royal Hospital, Oman (Former), Kilkenny, Ireland Author
  • Hiba Al Lawati School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Australia Author
  • Maimouna Al Mahrizi School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Australia 8University of Bristol, United Kingdom Author

DOI:

https://doi.org/10.32628/IJSRSET25122206

Keywords:

Spectrophotometry, Type 2 Diabetes Mellitus, insulin resistance, maltodextrin, dextrin, Stevia, glycemic index

Abstract

Spectrophotometric Analysis of Glycemic Risk from Dextrin and Maltodextrin: Implications for Type 2 Diabetes Mellitus and Insulin Resistance Aim: The growing global burden of Type 2 Diabetes Mellitus (T2DM) emphasizes the need for evaluating dietary components that influence glycemic control. Building on our previous systematic review (Part 1), this study expands the investigation through experimental spectrophotometric analysis, focusing on the quantification of dextrin and maltodextrin concentrations in commercial Stevia-based sweeteners and assessing their glycemic risk potential. Methods: Stevia sweetener solutions at four concentrations (100–400 mg/L) were analyzed using UV-Vis spectrophotometry at 580 nm following Lugol’s iodine staining. Calibration curves for dextrin and maltodextrin (50–500 mg/L) were constructed to estimate polysaccharide levels in the tested samples. Results: A dose-dependent increase in maltodextrin concentration was observed, ranging from 26.8 to 90.6 mg/L across the tested Stevia samples. Dextrin concentrations ranged from 9.9 to 35.9 mg/L. Higher sample concentrations correlated with elevated glycemic risk, with Stevia solutions at 300 mg/L and 400 mg/L demonstrating moderate to high potential for impacting blood glucose levels. Conclusion: The findings confirm that maltodextrin, even in products marketed as diabetic-friendly, may contribute to adverse glycemic responses in a concentration-dependent manner. Dextrin exhibited a comparatively safer metabolic profile. These results reinforce the importance of transparent food labeling and cautious dietary choices among individuals with or at risk for T2DM. This study serves as a direct continuation of our previously published systematic review (Part 1), bridging literature-based insights with experimental validation.

Downloads

Download data is not yet available.

References

Hu F, Niu Y, Xu X, et al. Nutrition & Metabolism. 2020;17:36.

Zheng Y, Ley SH, Hu FB. Nature Reviews Endocrinology. 2018;14(2):88-98.

Gibson GR, et al. Nutrition Research Reviews. 2004;17(2):259-275.

Jones JM. Nutrition Journal. 2014;13:34.

Aliasgharzadeh A, et al. British Journal of Nutrition. 2015;113(2):321-330.

Siro I, et al. Appetite. 2008;51(3):456-467.

Everard A, et al. Diabetes. 2011;60(11):2775-2786.

Cani PD, Delzenne NM. Current Pharmaceutical Design. 2009;15(13):1546-1558.

Roberfroid M. Critical Reviews in Food Science and Nutrition. 1993;33(2):103-148.

Slavin J. Nutrients. 2013;5(4):1417-1435.

Lovegrove A, et al. Critical Reviews in Food Science and Nutrition. 2017;57(2):237-253.

Turnbaugh PJ, et al. Nature. 2006;444(7122):1027-1031.

Qin J, et al. Nature. 2012;490(7418):55-60.

Ley RE, et al. Nature. 2006;444(7122):1022-1023.

Sonnenburg JL, et al. Science. 2005;307(5717):1955-1959.

Tremaroli V, Bäckhed F. Nature. 2012;489(7415):242-249.

Lozupone CA, Knight R. Nature Reviews Microbiology. 2008;6(10):782-792.

Cummings JH, Macfarlane GT. Gut. 1991;32(10):1235-1241.

Scott KP, et al. Gut Microbes. 2013;4(1):49-56.

Kellow NJ, Coughlan MT, Reid CM. Journal of Human Nutrition and Dietetics. 2014;27(1):1-13.

Delzenne NM, Cani PD. Pharmacological Research. 2010;61(3):367-373.

Slavin JL. International Journal of Food Sciences and Nutrition. 2008;59(S1):1-6.

Conlon MA, Bird AR. Nutrients. 2015;7(1):17-44.

Bindels LB, Delzenne NM, Cani PD, Walter J. Gut Microbes. 2015;6(2):159-171.

Round JL, Mazmanian SK. Nature Reviews Immunology. 2009;9(5):313-323.

David LA, et al. Nature. 2014;505(7484):559-563.

Rinninella E, et al. Microorganisms. 2019;7(1):14.

Bäckhed F, et al. Science. 2004;307(5717):1915-1920.

De Filippo C, et al. Proceedings of the National Academy of Sciences. 2010;107(33):14691-14696.

Wu GD, et al. Science. 2011;334(6052):105-108.

Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Nature Reviews Microbiology. 2012;10(4):220-232.

Roberfroid MB. Journal of Nutrition. 2007;137(11):2493S-2502S.

Louis P, Flint HJ. Applied and Environmental Microbiology. 2009;75(5):1057-1066.

Makki K, Deehan EC, Walter J, Bäckhed F. Cell Host & Microbe. 2018;23(6):705-715.

Guarner F, Malagelada JR. Lancet. 2003;361(9356):512-519.

Le Chatelier E, et al. Nature. 2013;500(7464):541-546.

Rowland I, et al. Nutrition Research Reviews. 2018;31(1):1-25.

Woting A, Blaut M. Frontiers in Microbiology. 2016;7:114.

Sonnenburg ED, Sonnenburg JL. Annual Review of Microbiology. 2019;73:1-25.

Binda C, et al. Journal of Functional Foods. 2020;67:103838.

Downloads

Published

30-04-2025

Issue

Section

Research Articles

How to Cite

[1]
Hassan Darwish, “Exploring the Metabolic Implications of Dextrin and Maltodextrin on Type 2 Diabetes Mellitus and Insulin Resistance: Experimental Glycemic Risk Analysis (Part 2)”, Int J Sci Res Sci Eng Technol, vol. 12, no. 2, pp. 823–827, Apr. 2025, doi: 10.32628/IJSRSET25122206.

Similar Articles

1-10 of 54

You may also start an advanced similarity search for this article.